Ranmali Bopitiya is CLO & VP at Oscar Health, Inc. (OSCR). They have made 6 open-market trades across 1 company since 2022, most recently 2024-12-02.
CIK 0001908069
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OSCR | 260,645 | $9.2M |
Shares reported on the most recent Form 4, priced at the 2024-12-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OSCR | SELL | 2024-12-02 | 2024-12-03 | $18.07 | $686K | -24.3% | -24.9% | -16.4% |
| OSCR | SELL | 2024-09-03 | 2024-09-04 | $17.82 | $2.2M | +26.6% | +16.3% | +3.9% |
| OSCR | SELL | 2024-06-03 | 2024-06-04 | $19.46 | $677K | -0.2% | -11.8% | -5.6% |
| OSCR | SELL | 2024-03-04 | 2024-03-05 | $15.88 | $363K | -2.5% | -1.5% | +35.3% |
| OSCR | SELL | 2024-02-16 | 2024-02-21 | $18.03 | $1.5M | -7.5% | -18.7% | +40.2% |
| OSCR | SELL | 2023-12-04 | 2023-12-05 | $8.34 | $211K | -4.5% | +5.9% | +87.7% |
| OSCR | SELL · 10b5-1 | 2023-09-05 | 2023-09-06 | $6.25 | $147K | -3.3% | -11.6% | +29.6% |
| OSCR | SELL · 10b5-1 | 2023-06-02 | 2023-06-05 | $7.15 | $166K | +13.9% | -5.6% | -24.4% |
| OSCR | SELL · 10b5-1 | 2023-03-02 | 2023-03-03 | $4.75 | $34K | -29.1% | +36.2% | +50.1% |
| OSCR | SELL · 10b5-1 | 2022-12-02 | 2022-12-05 | $2.84 | $18K | -17.6% | -5.8% | +70.9% |
| OSCR | SELL · 10b5-1 | 2022-09-02 | 2022-09-06 | $5.85 | $36K | +4.9% | -13.2% | -49.2% |
| OSCR | SELL · 10b5-1 | 2022-06-02 | 2022-06-03 | $4.69 | $28K | -16.0% | -3.7% | +20.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.